Jasper Therapeutics, Inc. (NASDAQ:JSPR) reported preliminary data from the ongoing BEACON Phase 1b/2a study of subcutaneous briquilimab in adult participants with chronic spontaneous urticaria (CSU).
Commissions do not affect our editors' opinions or evaluations. Young adults have evolving credit card needs. Many have shorter or non-existent credit histories and, for some, a life that revolves ...
A photo of the man’s face helped affirm his intuition. Mak ran the photo through a “face age” test, which showed that the 90-year-old man’s health was more similar to someone in their late ...
As 2024 crawls to a close, we look back at some of the stories from the entertainment world that resonated with Post readers during the year. A profile on an actress who went from soft-porn to ...